Article
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2018
Hu Yuebi, Ulrich Bryan C, Supplee Julianna, Kuang Yanan, Lizotte Patrick H, Feeney Nora B, Guibert Nicolas M, Awad Mark M, Wong Kwok-Kin, Jänne Pasi A, Paweletz Cloud P, Oxnard Geoffrey R
Abstract excerpt
Purpose: Plasma cell-free DNA (cfDNA) genotyping is increasingly used in cancer care, but assay accuracy has been debated. Because most cfDNA is derived from peripheral blood cells (PBC), we hypothesized that nonmalignant mutations harbored by hematopoietic cells (clonal hematopoiesis, CH) could be a cause of false-positive plasma genotyping.Experimental Design: We identified patients with advanced non-small cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
